Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda

CompletedOBSERVATIONAL
Enrollment

1,745

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

May 24, 2024

Study Completion Date

May 24, 2024

Conditions
Epilepsy
Interventions
DIAGNOSTIC_TEST

EEG

EEG registration performed in PwE to confirm epilepsy diagnosis

DIAGNOSTIC_TEST

Neuroimaging

Neuroimaging performed in PwE to diagnose epilepsy etiology

DIAGNOSTIC_TEST

Blood sample

Blood samples from both PwE and controls will be collected to measure full blood count, IgM and IgG antibodies to parasitic antigens including Taenia solium, Toxoplasma gondii and Plasmodium falciparum, to perform ELISA for HIV1 and HIV2, to measure HIV viral load and to conduct an emmel test.

OTHER

Risk factor questionnaire

Both PwE and control subjects will complete a structured questionnaire on a wide range of potential risk factors present before the onset of the epilepsy.

Trial Locations (1)

Unknown

King Faisal Hospital, Kigali

All Listed Sponsors
collaborator

King Faisal Specialist Hospital & Research Center

OTHER

lead

University Hospital, Ghent

OTHER